Everything below concerns peptide acylation. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-07-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
| Property | Value | Notes |
|---|---|---|
| Molar mass | approximately 4813 Da | calculated from the 39-residue sequence |
| Appearance | white to off-white powder | typical of lyophilised peptide material |
| Solubility class | freely soluble in water | measured value depends on salt form and pH |
| Plasma protein binding | >99 percent | linked to the fatty diacid side chain |
| Class | dual GIP and GLP-1 receptor agonist | receptor activity varies with the assay used |
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Common degradation routes include hydrolysis of labile amide bonds, deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation. Aggregates can form during freeze-thaw cycling, at elevated pH, or when peptide concentration is high. Each route produces characteristic chromatographic or mass shifts that are tracked during stability studies. Whether a given minor impurity alters biological activity is often an open question, and specification limits are typically set on identity and purity rather than on functional data for trace species.
Lyophilized material is generally held at -20 degrees Celsius or lower, desiccated and protected from light, where it remains stable for extended periods. Reconstituted or ready-to-use solution is usually kept at 2 to 8 degrees Celsius with minimal agitation. Repeated freeze-thaw cycles should be avoided because they promote aggregation and reduce the soluble monomer fraction. Shipment of frozen solid commonly uses dry ice, while refrigerated liquid moves with validated cold packs. Stability beyond documented periods is not established.
ligand An ion, functional group, or other molecule that binds to a central metal atom to form a coordination complex. Such bonding can range from covalent to ionic, but generally involves formal donation of one or more of the ligand's electron pairs to the metal.
The social organization of the earliest Paleolithic (Lower Paleolithic) societies remains largely unknown to scientists, though Lower Paleolithic hominins such as Homo habilis and Homo erectus are likely to have had more complex social structures than chimpanzee societies. Late Oldowan/Early Acheulean humans such as Homo ergaster/Homo erectus may have been the first people to invent central campsites or home bases and incorporate them into their foraging and hunting strategies like contemporary hunter-gatherers, possibly as early as 1.7 million years ago; however, the earliest solid evidence for the existence of home bases or central campsites (hearths and shelters) among humans only dates back to 500,000 years ago. Similarly, scientists disagree whether Lower Paleolithic humans were largely monogamous or polygynous. In particular, the Provisional model suggests that bipedalism arose in pre-Paleolithic australopithecine societies as an adaptation to monogamous lifestyles; however, other researchers note that sexual dimorphism is more pronounced in Lower Paleolithic humans such as Homo erectus than in modern humans, who are less polygynous than other primates, which suggests that Lower Paleolithic humans had a largely polygynous lifestyle, because species that have the most pronounced sexual dimorphism tend more likely to be polygynous. Human societies from the Paleolithic to the early Neolithic farming tribes lived without states and organized governments.
The Neolithic Revolution (or First Agricultural Revolution) brought about an acceleration of technological innovation, and a consequent increase in social complexity. The invention of the polished stone axe was a major advance that allowed large-scale forest clearance and farming. This use of polished stone axes increased greatly in the Neolithic but was originally used in the preceding Mesolithic in some areas such as Ireland. Agriculture fed larger populations, and the transition to sedentism allowed for the simultaneous raising of more children, as infants no longer needed to be carried around by nomads. Additionally, children could contribute labor to the raising of crops more readily than they could participate in hunter-gatherer activities. With this increase in population and availability of labor came an increase in labor specialization. What triggered the progression from early Neolithic villages to the first cities, such as Uruk, and the first civilizations, such as Sumer, is not specifically known; however, the emergence of increasingly hierarchical social structures and specialized labor, of trade and war among adjacent cultures, and the need for collective action to overcome environmental challenges such as irrigation, are all thought to have played a role. The invention of writing led to the spread of cultural knowledge and became the basis for history, libraries, schools, and scientific research.
Sources: en.wikipedia.org
== Clinical trials == The drug was reported to improve motivation and reduce apathy in people with Parkinson's disease in a phase 2a clinical trial. As of September 2024, pirepemat is in phase 2 clinical trials for Parkinson's disease. A phase 3 trial is being planned. The drug was also under development for the treatment of "behavioral disorders" and attention deficit hyperactivity disorder (ADHD). However, no recent development for the former indication has been reported and development for ADHD was discontinued. In August 2020, pirepemat received an INNTooltip International Nonproprietary Name with a novel suffix reflecting its reputedly new and unique mechanism of action. Pirepemat is under development by Integrative Research Laboratories (IRLAB).
Hemoglobin electrophoresis is a test that can detect different types of hemoglobin. Hemoglobin is extracted from the red cells, then introduced into a porous gel and subjected to an electrical field. This separates the normal and abnormal types of hemoglobin which can then be identified and quantified. Due to reduced production of HbA in beta thalassemia, the proportion of HbA2 and HbF relative to HbA are generally increased above normal. In alpha thalassemia the normal proportion is maintained. High-performance liquid chromatography (HPLC) is reliable, fully automated, and able to distinguish most types of abnormal hemoglobin including carriers, The method separates and quantifies hemoglobin fractions by measuring their rate of flow through a column of absorbent material. DNA analysis using polymerase chain reaction (PCR) or next-generation sequencing. These tests can identify carriers of thalassemia genes and combination hemoglobinopathies, as well as identifying the exact mutation which underlies the disease.
== Further reading == Al-Hussainy, Abbas Ali Abbas, "The civilized achievements of the Akkadian king Naram-Sin A Research in his Artistic Remains and The Date Formulas", ISIN Journal 3, 2022 Boissier, Alfred, "Inscription de Naram-Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 16, no. 3, pp. 157–64, 1919 Foster, B. R., "Naram-Sin in Martu and Magan", ARRIM 8, pp. 25–44, 1990 Glassner, J. J., "Naram-Sîn Poliorcète. Les avatars d'une sentence divinatoire", Revue d’Assyriologie et d’archéologie Orientale, vol. 77, no. 1, pp. 3–10, 1983 Grayson, A. Kirk, and Edmond Sollberger, "L’insurrection générale contre Narām-Suen", RA70, pp. 103–128, 1976 Lafont, Bertrand, "Une plaque en argile portant une inscription de Naram-Sin d'Agadé", The Third Millennium. Studies in Early Mesopotamia and Syria in Honor of Walter Sommerfeld and Manfred Krebernik, hrsg. v. Arkhipov, Ilya, Kogan, Leonid, Koslova, Natalia (Cuneiform Monographs 50), pp. 408–416, 2020 Piotr Michalowski, "New Sources concerning the Reign of Naram-Sin", Journal of Cuneiform Studies, vol. 32, no. 4, pp. 233–246, (Oct., 1980) Nassouhi, Essad, "Un vase en albatre de Naram - Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 22, no. 2, pp. 91–91, 1925 [12] A. Poebel, "The ‘Schachtelsatz’ Construction of the Naram-Sîn Text RA XVI 157f.", Miscellaneous Studies, AS 14; Chicago, pp.23–42, 1947 Powell, Marvin A., "Narām-Sîn, Son of Sargon: Ancient History, Famous Names, and a Famous Babylonian Forgery", Zeitschrift für Assyriologie und Vorderasiatische Archäologie, vol. 81, no. 1-2, pp.
We grew up internationally. My father thought of himself first and foremost as a Frenchman, and spent a few weeks every year with the elder children at Chambord, his main property on the Loire. I once asked him how we should describe ourselves. He replied, "We are French princes who reigned in Italy." In fact, of the twenty-four children only three including me, were actually born in Italy. At the age of ten, Zita was sent to a boarding school at Zanberg in Upper Bavaria, where there was a strict regime of study and religious instruction. She was summoned home in the autumn of 1907 at the death of her father. Her maternal grandmother sent Zita and her sister Francesca to a convent on the Isle of Wight to complete their education. Brought up as devout Catholics, the Parma children regularly undertook good works for the poor. In Schwarzau the family turned surplus cloth into clothes. Zita and Francesca personally distributed food, clothing, and medicines to the needy in Pianore. Three of Zita's sisters became nuns and, for a time, she considered following the same path. Zita went through a period of poor health and was sent for the traditional cure at a European spa for two years.
Sources: en.wikipedia.org
It is a synthetic peptide of 39 amino acids bearing a lipid side chain. Its size and architecture place it outside the small-molecule class, and laboratories generally handle it with the precautions used for biologic-like molecules.
The fatty diacid side chain promotes strong binding to serum albumin, which slows clearance and yields a half-life of roughly five days. That profile supports once-weekly administration in clinical use.
In vitro assays detect activity at both the GIP and GLP-1 receptors, but the activity ratio depends on the assay system and the signalling pathway measured. The relative contribution of each receptor to clinical effects is still being characterised.
Water promotes hydrolysis and deamidation, so removing it slows degradation during transport and storage. The dry solid is also less prone to microbial growth than a solution. Reconstitution is therefore performed close to the point of use.